Company intelligence / Profile preview

Sanofi Pasteur

Lyon, Francesanofi.com ↗
Ownership
Private
Employees
~15000
Development stage
Other
01

Overview

Sanofi Pasteur is the global vaccines business unit of Sanofi, serving as one of the world's largest producers of vaccines. It produces over 1 billion doses annually, protecting against more than 20 infectious diseases. Recent highlights include the successful commercialization of Beyfortus (nirsevimab) for RSV prevention in infants and the advancement of next-generation mRNA-based influenza vaccines.

Therapeutic areas
Infectious Diseases
Modalities
VaccinemRNA-based drugsRecombinant proteinMonoclonal antibodyBiologic
Industry
Pharma
02

Partnerships

GSKAstraZenecaSobiTranslate Bio

Beyond the preview

Go deeper on Sanofi Pasteur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanofi Pasteur.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call